No compound that could be linked to EVALI was found in the 2 nicotine products tested – only in the cannabinoid products, New York State Department of Health, the State University of New York at Albany and Albany Medical Center found. They analysed 38 liquid samples reportedly used by the first 10 cases of EVALI in New York State.


